Skip to main content

Table 1 Baseline characteristics of subjects categorized by aICAS

From: Association of the triglyceride glucose-waist height ratio with asymptomatic intracranial arterial stenosis

Characteristics

Overall

(N = 2000)

No aICAS

(N = 1854)

Any aICAS

(N = 146)

P value

Age (years),

median (IQR)

56(49, 65)

55(49, 65)

61(52, 69)

 < 0.001

Male sex, n (%)

958(47.9)

900(48.5)

58(39.7)

0.040

Smoking habit,

n (%)

447(22.4)

430(23.2)

17(11.6)

0.001

Drinking habit,

n (%)

657(32.9)

620(33.4)

37(25.3)

0.045

Education, n (%)

   

0.068

Below/Elementary school, n (%)

893(44.7)

815(44.0)

78(53.4)

 

Junior high school, n (%)

855(42.8)

800(43.1)

55(37.7)

 

Upon senior high school, n (%)

252(12.6)

239(12.9)

13(8.9)

 

Diabetes, n (%)

310(15.5)

265(14.3)

45(30.8)

 < 0.001

Dyslipidemia, n (%)

799(40.0)

729(39.3)

70(47.9)

0.041

Hypertension, n (%)

1154(57.7)

1034(55.8)

120(82.2)

 < 0.001

LDL-C (mg/dL), median (IQR)

2.94(2.53, 3.41)

2.93(2.52, 3.39)

3.10(2.59, 3.64)

0.012

HDL-C (mg/dL), median (IQR)

1.58(1.35, 1.87)

1.59(1.36, 1.88)

1.48(1.25, 1.64)

 < 0.001

hs-CRP (mg/L), median (IQR)

0.67(0.26, 1.58)

0.63(0.25, 1.53)

0.98(0.46, 2.30)

 < 0.001

TyG,

median (IQR)

8.54(8.17, 8.99)

8.53(8.16, 8.96)

8.81(8.39, 9.30)

 < 0.001

TyG-BMI,

median (IQR)

215.23

(190.68, 239.75)

214.62

(189.55, 238.59)

228.65

(205.02, 255.67)

 < 0.001

TyG-WC,

median (IQR)

785.76

(713.70, 863.71)

782.48

(711.47, 857.79)

840.06

(767.93, 917.91)

 < 0.001

TyG-WHR,

median (IQR)

7.87(7.31, 8.51)

7.85(7.29, 8.47)

8.27(7.60, 9.03)

 < 0.001

TyG-WHtR,

median (IQR)

4.92(4.45, 5.42)

4.90(4.43, 5.38)

5.33(4.81, 5.81)

 < 0.001

  1. IQR interquartile range, aICAS asymptomatic intracranial arterial stenosis, TyG triglyceride-glucose index, BMI body mass index, WC waist circumference, WHR waist-to-hip ratio, WHtR waist-to-height ratio, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein